The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 518
Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Valle, J. W., Armstrong, A., Newman, C., Alakhov, V., Pietrzynski, G., Brewer, J., Campbell, S., Corrie, P., Rowinsky, E. K., & Ranson, M. (2011) · Investigational New Drugs · doi:10.1007/s10637-010-9399-1 · Cited by 303
Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery
Parveen, S., & Sahoo, S. K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.023 · Cited by 302
Morgan, M. T., Nakanishi, Y., Kroll, D. J., Griset, A. P., Carnahan, M. A., Wathier, M., Oberlies, N. H., Manikumar, G., Wani, M. C., & Grinstaff, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2066 · Cited by 301
Aleku, M., Schulz, P., Keil, O., Santel, A., Schaeper, U., Dieckhoff, B., Janke, O., Endruschat, J., Durieux, B., Röder, N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2428 · Cited by 293
Gelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., & Kreuter, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293
Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603855 · Cited by 290
Giles, F. J., Kantarjian, H. M., Kornblau, S. M., Thomas, D. A., Garcia-Manero, G., Waddelow, T. A., David, C. L., Phan, A. T., Colburn, D. E., Rashid, A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<406::aid-cncr1336>3.0.co;2-u · Cited by 283
The Design and Development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®)
Molineux, G. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452613 · Cited by 283
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Vauthier, C. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.005 · Cited by 283
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
Banerjee, S. S., Aher, N., Patil, R., & Khandare, J. (2012) · Journal of Drug Delivery · doi:10.1155/2012/103973 · Cited by 282
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Targeting carbon nanotubes against cancer
Fabbro, C., Ali-Boucetta, H., Ros, T. D., Kostarelos, K., Bianco, A., & Prato, M. (2012) · Chemical Communications · doi:10.1039/c2cc17995d · Cited by 281
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
Cheng, P. N.-M., Lam, T.-L., Lam, W.-M., Tsui, S.-M., Cheng, A. W.-M., Lo, W.-H., & Leung, Y.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 277
Torchilin, V. P., Levchenko, T. S., Lukyanov, A. N., Khaw, B. A., Klibanov, A. L., Rammohan, R., Samokhin, G. P., & Whiteman, K. R. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2728(01)00165-7 · Cited by 271
Targeted drug delivery for cancer therapy: the other side of antibodies
Firer, M. A., & Gellerman, G. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-70 · Cited by 269
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research
Egusquiaguirre, S. P., Igartua, M., Hernández, R. M., & Pedraz, J. L. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0766-6 · Cited by 268
Zavaleta, C., de la Zerda, A., Liu, Z., Keren, S., Cheng, Z., Schipper, M., Chen, X., Dai, H., & Gambhir, S. S. (2008) · Nano Letters · doi:10.1021/nl801362a · Cited by 268
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
Talelli, M., Iman, M., Varkouhi, A. K., Rijcken, C. J. F., Schiffelers, R. M., Etrych, T., Ulbrich, K., van Nostrum, C. F., Lammers, T., Storm, G., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.005 · Cited by 267
Nanomedicine in cancer therapy: Innovative trends and prospects
Blanco, E., Hsiao, A., Mann, A. P., Landry, M. G., Meric‐Bernstam, F., & Ferrari, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01941.x · Cited by 265
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
Heister, E., Neves, V., Tîlmaciu, C., Lipert, K., Beltrán, V. S., Coley, H. M., Silva, S. R. P., & McFadden, J. (2009) · Carbon · doi:10.1016/j.carbon.2009.03.057 · Cited by 259
Prakash, S., Malhotra, M., Shao, W., Tomaro-Duchesneau, C., & Abbasi, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.013 · Cited by 256
Polymer therapeutics as nanomedicines: new perspectives
Duncan, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.05.507 · Cited by 254
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Dendritic Molecular Capsules for Hydrophobic Compounds
Morgan, M. T., Carnahan, M. A., Immoos, C. E., Ribeiro, A. A., Finkelstein, S., Lee, S. J., & Grinstaff, M. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0347383 · Cited by 252
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.007 · Cited by 252
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Liposomal drug formulations in cancer therapy: 15 years along the road
Slingerland, M., Guchelaar, H.-J., & Gelderblom, H. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.015 · Cited by 250
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Patri, A. K., Myc, A., Beals, J., Thomas, T. P., Bander, N. H., & Baker, J. R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249
Iwamoto, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-01102 · Cited by 247
Covalently Combining Carbon Nanotubes with Anticancer Agent: Preparation and Antitumor Activity
Wu, W., Li, R., Bian, X., Zhu, Z., Ding, D., Li, X., Jia, Z., Jiang, X., & Hu, Y. (2009) · ACS Nano · doi:10.1021/nn9005686 · Cited by 247
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246
Li, R., Wu, R., Zhao, L., Wu, M., Yang, L., & Zou, H. (2010) · ACS Nano · doi:10.1021/nn9011225 · Cited by 245
Hampel, S., Kunze, D., Haase, D., Krämer, K., Rauschenbach, M., Ritschel, M., Leonhardt, A., Thomas, J., Oswald, S., Hoffmann, V., et al. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.175 · Cited by 245
Mamot, C., Ritschard, R., Wicki, A., Stehle, G., Dieterle, T., Bubendorf, L., Hilker, C., Deuster, S., Herrmann, R., & Rochlitz, C. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70476-x · Cited by 244
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.056 · Cited by 242
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
Yang, X.-Z., Dou, S., Sun, T.-M., Mao, C.-Q., Wang, H.-X., & Wang, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.035 · Cited by 242
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat-Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 242
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Ajima, K., Murakami, T., Mizoguchi, Y., Tsuchida, K., Ichihashi, T., Iijima, S., & Yudasaka, M. (2008) · ACS Nano · doi:10.1021/nn800395t · Cited by 240
Chen, W., Meng, F., Li, F., Ji, S.-J., & Zhong, Z. (2009) · Biomacromolecules · doi:10.1021/bm900074d · Cited by 240
Wu, X. L., Kim, J. H., Koo, H., Bae, S. M., Shin, H., Kim, M. S., Lee, B.-H., Park, R.-W., Kim, I.-S., Choi, K., et al. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005283 · Cited by 239
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Kato, K., Chin, K., Yoshikawa, T., Yamaguchi, K., Tsuji, Y., Esaki, T., Sakai, K., Kimura, M., Hamaguchi, T., Shimada, Y., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9709-2 · Cited by 237
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Senzer, N., Nemunaitis, J., Nemunaitis, D., Bedell, C., Edelman, G., Barve, M., Nunan, R., Pirollo, K. F., Rait, A., & Chang, E. H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.32 · Cited by 236
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
Karmali, P. P., Kotamraju, V. R., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., & Ruoslahti, E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.007 · Cited by 234
Jain, A. K., Swarnakar, N. K., Godugu, C., Singh, R. P., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.037 · Cited by 232
Antibody‐Drug Conjugates for the Treatment of Cancer
Flygare, J. A., Pillow, T. H., & Aristoff, P. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12085 · Cited by 232
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 231
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 230
Duncan, R., & Vicent, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 230
Weiss, G. J., Chao, J., Neidhart, J. D., Ramanathan, R. K., Bassett, D., Neidhart, J. A., Choi, C. H. J., Chow, W., Chung, V., Forman, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9921-8 · Cited by 230
Kim, J.-H., Kim, Y.-S., Park, K., Kang, E., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Chi, D. Y., Park, R.-W., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.038 · Cited by 228
Hyperthermia-induced drug targeting
May, J. P., & Li, S.-D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.758631 · Cited by 228
Sommer, G., Rossa, C., Chi, A. C., Neville, B. W., & Heise, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025402 · Cited by 228
The clinical efficacy of poly(ethylene glycol)-modified proteins
Fuertges, F., & Abuchowski, A. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90127-f · Cited by 226
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Lipoplatin Formulation Review Article
Stathopoulos, G. P., & Boulikas, T. (2012) · Journal of Drug Delivery · doi:10.1155/2012/581363 · Cited by 224
Folate-decorated nanogels for targeted therapy of ovarian cancer
Nukolova, N. V., Oberoi, H. S., Cohen, S. M., Kabanov, A. V., & Bronich, T. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.006 · Cited by 223
Begcy, K., Mariano, E. D., Mattiello, L., Nunes, A. V., Mazzafera, P., Maia, I. G., & Menossi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023776 · Cited by 221
Development and characterization of a novel liposome-based formulation of SN-38
Zhang, J. A., Xuan, T., Parmar, M., Ma, L., Ugwu, S., Ali, S., & Ahmad, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.015 · Cited by 220
Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 219
Barraud, L., Merle, P., Soma, E., Lefrançois, L., Guerret, S., Chevallier, M., Dubernet, C., Couvreur, P., Trépo, C., & Vitvitski, L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.035 · Cited by 217
Progress Toward In Vivo Use of siRNAs-II
Rettig, G. R., & Behlke, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2011.263 · Cited by 217
Jain, A., Jain, S. K., Ganesh, N., Barve, J., & Beg, A. M. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.03.002 · Cited by 214
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb
Shukla, R., Thomas, T. P., Peters, J. L., Desai, A. M., Kukowska-Latallo, J., Patri, A. K., Kotlyar, A., & Baker, J. R. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050348p · Cited by 213
Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S. K. L., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 213
Design of Dendritic Macromolecules Containing Folate or Methotrexate Residues
Kono, K., Liu, M., & Fréchet, J. M. J. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990082k · Cited by 207
Gan, C. W., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.053 · Cited by 207
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Development of liposomal formulations: From concept to clinical investigations
Fan, Y., & Zhang, Q. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.010 · Cited by 206
Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Shukla, R., Thomas, T. P., Peters, J., Kotlyar, A., Myc, A., & Baker, Jr. (2005) · Chemical Communications · doi:10.1039/b507350b · Cited by 205
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K.-T., Burnett, J., & Rossi, J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 205
Ji, Z., Lin, G., Lu, Q., Meng, L., Shen, X., Dong, L., Fu, C., & Zhang, X. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.09.013 · Cited by 205
Desai, N. P., Trieu, V., Hwang, L. Y., Wu, R., Soon-Shiong, P., & Gradishar, W. J. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32830f9046 · Cited by 205
Langer, C. J., O’Byrne, K. J., Socinski, M. A., Mikhailov, S. M., Leśniewski-Kmak, K., Smakal, M., Ciuleanu, T. E., Orlov, S. V., Dediu, M., Heigener, D., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181753b4b · Cited by 202
Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intravenous Injection
Christie, R. J., Matsumoto, Y., Miyata, K., Nomoto, T., Fukushima, S., Osada, K., Halnaut, J., Pittella, F., Kim, H. J., Nishiyama, N., et al. (2012) · ACS Nano · doi:10.1021/nn300942b · Cited by 193
In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer Nanoparticles
Thomas, T. P., Patri, A. K., Myc, A., Myaing, M. T., Ye, J. Y., Norris, T. B., & Baker, J. R. (2004) · Biomacromolecules · doi:10.1021/bm049704h · Cited by 193
Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists
Li, M. C., Hertz, R., & Bergenstal, D. M. (1958) · New England Journal of Medicine · doi:10.1056/nejm195807102590204 · Cited by 189
Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P., Martinez, A., Gao, Y., Lozanguiez, Y., Longley, C., et al. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700333s · Cited by 188
Antibody–drug conjugates for cancer: poised to deliver?
Hughes, B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3270 · Cited by 188
Bae, K. H., Lee, K., Kim, C., & Park, T. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.039 · Cited by 188
Novel applications of nanotechnology in medicine.
Surendiran, A., Sandhiya, S., Pradhan, S. C., & Adithan, C. (2009) · PubMed · Cited by 188
Couvreur, P., Kante, B., Roland, M., & Speiser, P. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681215 · Cited by 186
Wu, H., Chang, D.-K., & Huang, C.-T. (2006) · Cited by 185
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Cheng, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2774 · Cited by 184
Johannsen, M., Spitaleri, G., Curigliano, G., Roigas, J., Weikert, S., Kempkensteffen, C., Roemer, A., Kloeters, C., Rogalla, P., Pecher, G., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.033 · Cited by 183
The story of taxol: nature and politics in the pursuit of an anti-cancer drug
(2001) · Choice Reviews Online · doi:10.5860/choice.39-0970 · Cited by 182
The development and therapeutic potential of protein kinase inhibitors
Cohen, P. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80067-2 · Cited by 182
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., & Stewart, J. S. W. (2001) · Annals of Oncology · doi:10.1023/a:1011199028318 · Cited by 182
Tumor targeting using liposomal antineoplastic drugs
Huwyler, J. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1253 · Cited by 182
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
Chittasupho, C., Xie, S.-X., Baoum, A., Yakovleva, T., Siahaan, T. J., & Berkland, C. J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.008 · Cited by 181
Synthesis and Biological Evaluation of a Bioresponsive and Endosomolytic siRNA−Polymer Conjugate
Meyer, M., Dohmen, C., Philipp, A., Kiener, D., Maiwald, G., Scheu, C., Ogris, M., & Wagner, E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000124 · Cited by 180
Miller, K., Erez, R., Segal, E., Shabat, D., & Satchi‐Fainaro, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805133 · Cited by 179
Wu, G., Barth, R. F., Yang, W., Kawabata, S., Zhang, L., & Green-Church, K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0325 · Cited by 177
Bhirde, A. A., Patel, S., Sousa, A. A., Patel, V., Molinolo, A. A., Ji, Y., Leapman, R. D., Gutkind, J. S., & Rusling, J. F. (2010) · Nanomedicine · doi:10.2217/nnm.10.90 · Cited by 177
Drug Targeting Strategies in Cancer Treatment: An Overview
L. Arias, J. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564024 · Cited by 176
Duan, J., Zhang, Y., Han, S., Chen, Y., Li, B., Liao, M., Chen, W., Deng, X., Zhao, J., & Huang, B. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.033 · Cited by 175
Jungbluth, A. A., Stockert, E., Huang, H. J. S., Collins, V. P., Coplan, K., Iversen, K., Kolb, D., Johns, T. J., Scott, A. M., Gullick, W. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232686499 · Cited by 174
Dijkgraaf, I., Rijnders, A. Y., Soede, A., Dechesne, A. C., van Esse, G. W., Brouwer, A. J., Corstens, F. H. M., Boerman, O. C., Rijkers, D. T. S., & Liskamp, R. M. J. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b615940k · Cited by 174
Widera, A., Norouziyan, F., & Shen, W.-C. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.004 · Cited by 173
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173
Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
Zamboni, W. C. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0180 · Cited by 173
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Davis, M. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.005 · Cited by 171
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Benny, O., Fainaru, O., Adini, A., Cassiola, F., Bazinet, L., Adini, I., Pravda, E., Nahmias, Y., Koirala, S., Corfas, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1415 · Cited by 171
Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D. S., Basta, M., Stahl, G. L., Bünger, R., & Alving, C. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1319 · Cited by 171
Lee, S.-W., Yun, M.-H., Jeong, S. W., In, C.-H., Kim, J.-Y., Seo, M.-H., Pai, C.-M., & Kim, S.-O. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.012 · Cited by 169
Zhu, Z., Li, Y., Li, X., Li, R., Jia, Z., Li, R., Guo, W., Wu, W., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.002 · Cited by 169
Kurzrock, R., Gabrail, N., Chandhasin, C., Moulder, S., Smith, C., Brenner, A., Sankhala, K., Mita, A., Elian, K., Bouchard, D., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0566 · Cited by 168
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
Nowotnik, D. P., & Cvitkovic, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.004 · Cited by 167
Kono, K., Ozawa, T., Yoshida, T., Ozaki, F., Ishizaka, Y., Maruyama, K., Kojima, C., Harada, A., & Aoshima, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.045 · Cited by 167
Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System
Ke, W., Zhao, Y., Huang, R., Jiang, C., & Pei, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21155 · Cited by 165
Activity of Dendrimer−Methotrexate Conjugates on Methotrexate-Sensitive and -Resistant Cell Lines
Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., & Kannan, R. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0501855 · Cited by 165
Bartlett, D. W., & Davis, M. E. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21668 · Cited by 164
Wohlfart, S., Khalansky, A. S., Gelperina, S., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model
Bernardi, A., Braganhol, E., Jäger, E., Figueiró, F., Edelweiss, M. I., Pohlmann, A. R., Guterres, S. S., & Battastini, A. M. O. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.018 · Cited by 161
Adeli, M., Soleyman, R., Beiranvand, Z., & Madani, F. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35431h · Cited by 160
Unezaki, S., Maruyama, K., Hosoda, J.-I., Nagae, I., Koyanagi, Y., Nakata, M., Ishida, O., Iwatsuru, M., & Tsuchiya, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04674-1 · Cited by 158
Heparin–deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity
Park, K., Lee, G. Y., Kim, Y.-S., Yu, M., Park, R.-W., Kim, I.-S., Kim, S. Y., & Byun, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.017 · Cited by 158
Lee, S. J., Huh, M. S., Lee, S. Y., Min, S., Lee, S., Koo, H., Chu, J., Lee, K. E., Jeon, H., Choi, Y., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201390 · Cited by 158
Antibody–Drug Conjugate (ADC) Clinical Pipeline: A Review
Sassoon, I., & Blanc, V. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5_1 · Cited by 157
Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Fu, Q., Sun, J., Zhang, W., et al. (2009) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489209789206869 · Cited by 157
Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156
Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications
Mousa, S. A., & Bharali, D. J. (2011) · Cancers · doi:10.3390/cancers3032888 · Cited by 156
A review of polysaccharide cytotoxic drug conjugates for cancer therapy
Goodarzi, N., Varshochian, R., Kamalinia, G., Atyabi, F., & Dinarvand, R. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.10.036 · Cited by 154
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Svenson, S., Wolfgang, M., Hwang, J., Ryan, J. L., & Eliasof, S. D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.007 · Cited by 153
Polymer–drug conjugates as nano-sized medicines
Canal, F., Sanchis, J., & Vicent, M. J. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.003 · Cited by 153
Peptide‐mediated targeted drug delivery
Majumdar, S., & Siahaan, T. J. (2010) · Medicinal Research Reviews · doi:10.1002/med.20225 · Cited by 152
Samorì, C., Ali‐Boucetta, H., Sainz, R., Guo, C., Toma, F. M., Fabbro, C., Ros, T. D., Prato, M., Kostarelos, K., & Bianco, A. (2009) · Chemical Communications · doi:10.1039/b923560d · Cited by 152
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Danhauser-riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., & Hanauske, A.-R. (1993) · Investigational New Drugs · doi:10.1007/bf00874153 · Cited by 152
Sandborn, W. J., Abreu, M. T., D’Haens, G., Colombel, J., Vermeire, S., Mitchev, K., Jamoul, C., Fedorak, R. N., Spehlmann, M. E., Wolf, D. C., et al. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.04.021 · Cited by 152
White, S. C., Lorigan, P. C., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 152
Mifamurtide for the treatment of nonmetastatic osteosarcoma
Ando, K., Mori, K., Corradini, N., Rédiní, F., & Heymann, D. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.543129 · Cited by 150
Szebeni, J. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.50 · Cited by 147
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia
Macdougall, I. C., & Eckardt, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69120-4 · Cited by 146
Hamaguchi, T., Doi, T., Nakajima, T. E., Kato, K., Yamada, Y., Shimada, Y., Fuse, N., Ohtsu, A., Matsumoto, S.-I., Takanashi, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0387 · Cited by 145
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Lammers, T., Šubr, V., Ulbrich, K., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nano Today · doi:10.1016/j.nantod.2010.05.001 · Cited by 145
A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
Wang, X., Li, J., Wang, Y., Koenig, L., Gjyrezi, A., Giannakakou, P., Shin, E. H., Tighiouart, M., Chen, Z. (., Nie, S., et al. (2011) · ACS Nano · doi:10.1021/nn200739q · Cited by 145
Bhardwaj, V., Ankola, D. D., Gupta, S., Schneider, M., Lehr, C., & Kumar, M. N. V. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9965-4 · Cited by 145
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
Okarvi, S. M. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.07.017 · Cited by 145
Protein, peptide and non-peptide drug PEGylation for therapeutic application
Pasut, G., Guiotto, A., & Veronese, F. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.859 · Cited by 145
Datir, S. R., Das, M., Singh, R. P., & Jain, S. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300248t · Cited by 145
Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
Rowe, J. M., & Löwenberg, B. (2013) · Blood · doi:10.1182/blood-2013-03-490482 · Cited by 143
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
RGD-modified PEG–PAMAM–DOX conjugates: In vitro and in vivo studies for glioma
Zhang, L., Zhu, S., Qian, L., Pei, Y., Qiu, Y., & Jiang, Y. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.025 · Cited by 137
The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity
Alley, S. C., Zhang, X., Okeley, N. M., Anderson, M. E., Law, C., Senter, P. D., & Benjamin, D. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155549 · Cited by 136
High-Frequency Ultrasound-Responsive Block Copolymer Micelle
Wang, J., Pelletier, M., Zhang, H., Xia, H., & Zhao, Y. (2009) · Langmuir · doi:10.1021/la9018794 · Cited by 135
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
Talelli, M., Oliveira, S., Rijcken, C. J. F., Pieters, E. H. E., Etrych, T., Ulbrich, K., van Nostrum, R., Storm, G., Hennink, W. E., & Lammers, T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.064 · Cited by 132
Wood, B. J., Poon, R. T. P., Locklin, J. K., Dreher, M. R., Ng, K. K., Eugeni, M. A., Seidel, G., Dromi, S. A., Neeman, Z., Kolf, M., et al. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2011.10.018 · Cited by 132
The Roles of the Methyl-CpG Binding Proteins in Cancer
Parry, L., & Clarke, A. R. (2011) · Genes & Cancer · doi:10.1177/1947601911418499 · Cited by 131
Application of liposomal technologies for delivery of platinum analogs in oncology
Wang, A. Z., Lin, W., Liu, D., & He, C. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38354 · Cited by 130
Functional dendritic polymer architectures as stimuli-responsive nanocarriers
Calderón, M., Quadir, M., Strumia, M. C., & Haag, R. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.017 · Cited by 130
Mifamurtide: A Review of its Use in the Treatment of Osteosarcoma
Frampton, J. E. (2010) · Pediatric Drugs · doi:10.2165/11204910-000000000-00000 · Cited by 128
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Sabbatini, P. J., Aghajanian, C. A., Dizon, D. S., Anderson, S., Dupont, J., Brown, J. V., Peters, W. A., Jacobs, A. D., Mehdi, A., Rivkin, S. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.043 · Cited by 125
Lammers, T., Peschke, P., Kühnlein, R., Subr, V., Ulbrich, K., Debus, J., Huber, P., Hennink, W., & Storm, G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.032 · Cited by 124
Zabaleta, V., Ponchel, G., Salman, H. H., Agüeros, M., Vauthier, C., & Irache, J. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.001 · Cited by 123
Papac, R. J. (2001) · PubMed Central · Cited by 123
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
Eldar-Boock, A., Miller, K., Sanchis, J., Lupu, R., Vicent, M., & Satchi-Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.073 · Cited by 120
Zhang, C., Zhao, L., Dong, Y., Zhang, X., Lin, J., & Chen, Z. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.005 · Cited by 120
Clinical pharmacology of polyethylene glycol-L-asparaginase.
Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M. J., Abuchowski, A., Newman, R. A., & Krakoff, I. H. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08348-5 · Cited by 119
Immunoliposomes for cancer therapy.
Kontermann, R. E. (2006) · PubMed · Cited by 117
Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
Dohmen, C., Fröhlich, T., Lächelt, U., Röhl, I., Vornlocher, H., Hadwiger, P., & Wagner, E. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2011.10 · Cited by 117
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopečková, P., Kopec̆ek, J., & Satchi‐Fainaro, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005233 · Cited by 116
Design, Synthesis, and Biological Evaluation of a Robust, Biodegradable Dendrimer
van der Poll, D. G., Ferguson, H. M., Floyd, W. C., Guillaudeu, S. J., Jerger, K., Szoka, F. C., & Fréchet, J. M. J. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900553n · Cited by 115
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Drummond, D. C., Noble, C. O., Guo, Z., Hayes, M. E., Connolly-Ingram, C., Gabriel, B. S., Hann, B. C., Liu, B., Park, J. W., & Hong, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.006 · Cited by 115
Calderón, M., Welker, P., Licha, K., Fichtner, I., Graeser, R., Haag, R., & Kratz, F. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.017 · Cited by 114
Li, J., Wang, Y., Yang, C., Wang, P., Oelschlager, D. K., Zheng, Y., Tian, D.-A., Grizzle, W. E., Buchsbaum, D. J., & Wan, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054551 · Cited by 114
Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
Nokisalmi, P., Pesonen, S. A., Escutenaire, S., Särkioja, M., Raki, M., Cerullo, V., Laasonen, L., Alemany, R., Rojas, J. J., Cascalló, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3167 · Cited by 113
Targeting neuropilin-1 in human leukemia and lymphoma
Karjalainen, K., Jaalouk, D. E., Bueso-Ramos, C., Zurita, A. J., Kuniyasu, A., Eckhardt, B. L., Marini, F. C., Lichtiger, B., O'Brien, S. M., Kantarjian, H. M., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282921 · Cited by 113
Improved therapeutic effect of folate-decorated PLGA–PEG nanoparticles for endometrial carcinoma
Liang, C., Yang, Y., Ling, Y., Huang, Y., Li, T. X., & Li, X. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.016 · Cited by 111
Zhao, L., & Feng, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22113 · Cited by 109
Recent Advances in Basic and Clinical Nanomedicine
Morrow, K. J., Bawa, R., & Wei, C. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.05.009 · Cited by 109
Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 109
Kimball, K. J., Preuss, M. A., Barnes, M. N., Wang, M., Siegal, G. P., Wan, W., Kuo, H., Saddekni, S., Stockard, C. R., Grizzle, W. E., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0791 · Cited by 109
CRLX101 (formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development
Young, C., Schluep, T., Hwang, J., & Eliasof, S. D. (2011) · Current Bioactive Compounds · doi:10.2174/157340711795163866 · Cited by 108
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.
Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles
Hong, M., Zhu, S., Jiang, Y., Tang, G., Sun, C. Z., Fang, C., Shi, B., & Pei, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.024 · Cited by 106
Cirstoiu-Hapca, A., Buchegger, F., Lange, N., Bossy-Nobs, L., Gurny, R., & Delié, F. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.026 · Cited by 105
Kulkarni, A., DeFrees, K., Hyun, S., & Thompson, D. H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300690j · Cited by 105
Rituximab: A New Therapeutic Monoclonal Antibody for Non‐Hodgkin's Lymphoma
Scott, S. D. (1998) · Cancer Practice · doi:10.1046/j.1523-5394.1998.006003195.x · Cited by 105
Bassi, P. F., Volpe, A., D’Agostino, D., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.09.073 · Cited by 104
Iriyama, N., Yoshino, Y., Yuan, B., Horikoshi, A., Hirabayashi, Y., Hatta, Y., Toyoda, H., & Takeuchi, J. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-1 · Cited by 104
Feldman, E. J., Kolitz, J. E., Trang, J. M., Liboiron, B. D., Swenson, C. E., Chiarella, M. T., Mayer, L. D., Louie, A. C., & Lancet, J. E. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.07.006 · Cited by 103
Homsi, J., Simon, G. R., Garrett, C. R., Springett, G. M., Conti, R. C. D., Chiappori, A., Münster, P. N., Burton, M. K., Stromatt, S. C., Allievi, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2821 · Cited by 103
Winer, I. S., Wang, S., Lee, Y.-E. K., Fan, W., Gong, Y., Burgos-Ojeda, D., Spahlinger, G., Kopelman, R., & Buckanovich, R. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1917 · Cited by 102
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024075 · Cited by 102
Wang, Z., Chui, W., & Ho, P. C. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9837-y · Cited by 100
Cited by
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Liu, Y., Bhattarai, P., Dai, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00618k · Cited by 2,904
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Metadata
- Authors
- Pérez-Herrero, E., & Fernández-Medarde, A.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 93
- Pages
- 52-79
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2100173894
- Cited by
- 1,875
- References
- 518
- FWCI
- 34.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.